On fundamental mechanisms of action,
P28R is active
in a number of human cancers.

donePotent immunomodulation

CanImGuide has developed the proprietary drug P28R

CanImGuide has founded a subsidiary company to focus exclusively on the research and development of P28R. This new company is called Immodulate Pharma AB. We welcome you to visit our new website to find out information on the latest developments
Menu